European Case Law Identifier: | ECLI:EP:BA:2000:T083897.20001114 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 14 November 2000 | ||||||||
Case number: | T 0838/97 | ||||||||
Application number: | 84112647.7 | ||||||||
IPC class: | C12N 15/11 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | B | ||||||||
Download and more information: |
|
||||||||
Title of application: | Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA | ||||||||
Applicant name: | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | ||||||||
Opponent name: | Calgene Inc. | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | State of the art - Gordon Research Conference - public (no) - confidentiality agreement Novelty (yes) Inventive step (yes) Sufficiency of disclosure (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970838eu1.html
Date retrieved: 17 May 2021